Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
OneSource Regulatory™ introduces MyIndago™
|
||||||
The first FREE Search and Discussion Solution to Search FDA Warning and Enforcement Actions, and Office of Inspector General (OIG) Corporate Integrity Agreements and OIG Advisory Opinions
CHICAGO, IL, October 16, 2017 – OneSource Regulatory™ (OSR), the premier specialized technology-enabled professional services firm, today announced a free technology solution for individuals working in the life sciences industry, with the launch of MyIndago™.
MyIndago™ is the most effective solution for professionals working in the highly-regulated FDA environment, striving to help pharmaceutical companies maintain compliance. With MyIndago™, individuals can easily search and access FDA enforcement communications to gain transparency into what has been problematic according to the FDA. Typically, this information is posted by the FDA at the time of communication and can be accessed on their webpage, but it is not easily searchable or cataloged within a user-friendly environment. Instead of a high-priced subscription database, available only to employees in the largest organizations, MyIndago™ is a free solution available to everyone.
Co-founder and visionary of OSR, Tracy Rockney, speaks to the value of MyIndago™ as an innovative technology: “With MyIndago™, accurate information is readily available to empower decision-making to anyone, at all levels of the organization.”
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/47cf2750-9c2c-41c9-b97e-826e97ccee57
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/dcf3fa31-838e-4766-8f6c-bfb4c8f7ad38
Tracy D. Rockney-Ward OneSource Regulatory +1 (833) OSR-TEAM [email protected]
